Medical Director
Ascendis Pharma A/S · Kailera Therapeutics, Inc. · Merck Sharp & Dohme LLC
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Medical Director as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:55 UTC. Showing 200 of 4165. Open this list on ClinicalTrials.gov
- Ph3NCT07924059 · Phase 3 Clinical Trial Evaluating the Efficacy and Safety of Navepegritide and Lonapegsomatropin in AchondroplasiaAscendis Pharma A/S · not yet recruiting · Achondroplasia · study director
- Ph1NCT07924761 · A Study to Investigate the Effect of Injection Site and Ethnicity on KAI-4729 Pharmacokinetics in Non-Asian and Asian Participants Living With Obesity or OverweightKailera · not yet recruiting · Overweight or Obesity · study director
- Ph1NCT07922174 · A Clinical Trial of MK-6916 in Participants With Moderate and Severe Kidney Disease Compared to Healthy Controls (MK-6916-013)Merck Sharp & Dohme LLC · not yet recruiting · Healthy, Renal Impairment · study director
- Ph1NCT07923071 · A Study to Assess the Pharmacokinetics and Safety of Revumenib in Participants With Advanced Cancer and Hepatic or Renal ImpairmentSyndax Pharmaceuticals · not yet recruiting · Relapsed/Refractory (R/R) Hematologic Malignancies, Acute Leukemia, Refractory Leukemia · study director
- Ph2/Ph3NCT07917754 · A Clinical Trial of MK-1045 With Zilovertamab Vedotin in Participants With Diffuse Large B-cell Lymphoma (MK-1045-010)Merck Sharp & Dohme LLC · not yet recruiting · Lymphoma, Large B-Cell, Diffuse, Diffuse Large B-Cell Lymphoma · study director
- Ph1NCT07919028 · A Clinical Trial of MK-7602 in Healthy Volunteers (MK-7602-006)Merck Sharp & Dohme LLC · not yet recruiting · Healthy · study director
- Ph3NCT07917143 · A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide Versus Placebo in Children and Adolescents With HypochondroplasiaAscendis Pharma A/S · not yet recruiting · Hypochondroplasia · study director
- Ph3NCT07908537 · A Clinical Trial of Gocatamig (MK-6070) With Durvalumab in Participants With Small Cell Lung Cancer (MK-6070-004)Merck Sharp & Dohme LLC · not yet recruiting · Small Cell Lung Cancer · study director
- Ph1/Ph2NCT07908524 · MK-2870-U01 Substudy 1: A Clinical Trial of Sacituzumab Tirumotecan to Treat Prostate Cancer (MK-2870-01A)Merck Sharp & Dohme LLC · not yet recruiting · Metastatic Castration-resistant Prostate Cancer · study director
- N/ANCT07906639 · A Study of Fatigue, Itching and Daily Activities in People With Primary Biliary Cholangitis Starting ElafibranorIpsen · not yet recruiting · Primary Biliary Cholangitis (PBC) · study director
- Ph2NCT07901179 · A Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive DisorderAlkermes, Inc. · recruiting · Major Depressive Disorder (MDD) · study director
- Ph4NCT07899905 · A Clinical Study of MK-7962 in Chinese Participants With Pulmonary Arterial Hypertension (MK-7962-022)Merck Sharp & Dohme LLC · not yet recruiting · Hypertension, Pulmonary · study director
- Ph2NCT07895524 · A Clinical Trial of MK-8690 in Participants With Rheumatoid Arthritis (MK-8690-004)Merck Sharp & Dohme LLC · not yet recruiting · Rheumatoid Arthritis · study director
- Ph2NCT07889362 · A Study to Learn About the Effects of Felzartamab on the Kidneys of Adults With Immunoglobulin A Nephropathy (IgAN)Biogen · not yet recruiting · Immunoglobulin A Nephropathy · study director
- N/ANCT07887828 · A Study to Learn More About Friedrich's Ataxia in People Living in the Gulf Cooperation Council (GCC) Region of the WorldBiogen · not yet recruiting · Friedreich's Ataxia · study director
- Ph1/Ph2NCT07876804 · A Long-term Follow-up Study in Male Participants With X-linked Myotubular Myopathy Treated With ASP2957Astellas Gene Therapies · not yet recruiting · X-linked Myotubular Myopathy · study director
- Ph3NCT07874815 · Ensifentrine (MK-5884) Study for the Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Adults With a History of Moderate or Severe Exacerbations While Receiving Standard of Care (SOC) (MK-5884-031/RPL554/ENHANCE-3)Merck Sharp & Dohme LLC · recruiting · Pulmonary Disease, Chronic Obstructive · study director
- Ph1/Ph2NCT07876128 · A Clinical Trial of MK-2750 in Participants With Advanced Solid Tumors (MK-2750-002)Merck Sharp & Dohme LLC · not yet recruiting · Advanced Solid Tumors, Malignant Neoplasm · study director
- Ph1/Ph2NCT07873827 · KATALYST-HEME-01: Study of the KAT6 Inhibitor MEN2312 in Heme MalignanciesStemline Therapeutics, Inc. · not yet recruiting · Hematological Malignancy · study director
- Ph1NCT07870278 · A Clinical Trial of MK-6255 to Treat Endometrial and Ovarian Cancer (MK-6255-001)Merck Sharp & Dohme LLC · not yet recruiting · Ovarian Neoplasms, Endometrial Neoplasms · study director
- Ph2NCT07869147 · Study of ORJ-001 for the Treatment of IPFOorja Bio, Inc. · recruiting · Idiopathic Pulmonary Fibrosis · study director
- Ph2NCT07867938 · A Clinical Trial of Tulisokibart (MK-7240) in Participants With Pulmonary Sarcoidosis (MK-7240-016)Merck Sharp & Dohme LLC · recruiting · Pulmonary Sarcoidosis · study director
- Ph2NCT07862595 · A Clinical Trial of MK-6916 in Participants With Pain After Bunion Removal Surgery (MK-6916-007)Merck Sharp & Dohme LLC · not yet recruiting · Pain Management · study director
- Ph1NCT07862621 · A Clinical Trial of MK-6916 With Midazolam and Rosuvastatin in Healthy Participants (MK-6916-012)Merck Sharp & Dohme LLC · not yet recruiting · Healthy · study director
- Ph2NCT07861074 · A Clinical Trial Of Tulisokibart In Participants With Active, Non-Infectious Uveitis (MK-7240-019)Merck Sharp & Dohme LLC · recruiting · Noninfectious Intermediate, Posterior, or Panuveitis · study director
- Ph1/Ph2NCT07855211 · A Study to Learn About the Safety of BIIB147 and Its Effects in Adults With Amyotrophic Lateral Sclerosis (ALS)Biogen · recruiting · Amyotrophic Lateral Sclerosis · study director
- Ph1NCT07855510 · A Clinical Trial of V175 and V175A in Healthy AdultsMerck Sharp & Dohme LLC · recruiting · Lower Respiratory Tract Infection · study director
- N/ANCT07855562 · MPS IIIA Disease Monitoring ProgramUltragenyx Pharmaceutical Inc · not yet recruiting · MPS IIIA, Sanfilippo Syndrome, Sanfilippo A · study director
- Ph2NCT07850609 · A Clinical Study of Alimatravir (MK-8527) in Transgender (Trans) and Gender Diverse Individuals on Gender-affirming Hormone Therapy and at Low Likelihood of Human Immunodeficiency Virus (HIV)-1 Exposure (MK-8527-018)Merck Sharp & Dohme LLC · not yet recruiting · HIV · study director
- Ph1NCT07850310 · A Clinical Trial of MK-8644 in Healthy Participants and Participants With Psoriasis (MK-8644-001)Merck Sharp & Dohme LLC · recruiting · Psoriasis, Healthy · study director
- Ph3NCT07846280 · Study to Assess the Long-term Safety of KN3835 in the Treatment and Retreatment of Flexible/Semi-Flexible Hammertoe (HMT)Endo USA Inc., a Keenova Therapeutics Company · not yet recruiting · Flexible Hammertoe, Semi-flexible Hammertoe · study director
- Ph2NCT07845786 · Zanzalintinib and Pembrolizumab in First-Line Maintenance for Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)Exelixis · not yet recruiting · Squamous Non-Small Cell Lung Cancer (NSCLC) · study director
- Ph1NCT07838987 · A Clinical Trial to Evaluate MK-4208/Embibatinib in Healthy Adult Participants (MK-4208-001/Embibatinib-1014)Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · completed · Healthy · study director
- Ph3NCT07839585 · A Clinical Study of Sotatercept (MK-7962) in People With Combined Postcapillary and Precapillary Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (MK-7962-041)Merck Sharp & Dohme LLC · not yet recruiting · Pulmonary Hypertension · study director
- Ph1NCT07839000 · A Clinical Trial to Evaluate [14C]-MK-4208/[14C]-TERN-701 in Healthy Adult Male Participants (MK-4208-002/TERN701-1016)Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · completed · Healthy · study director
- Ph1NCT07836452 · A Phase 1, First-in-Human Study of CITY-RBP4 in Healthy Volunteers and STGD1 ParticipantsCity Therapeutics · recruiting · Stargardt Disease 1, STGD1, Healthy Volunteers · study director
- Ph3NCT07829783 · A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) and Pembrolizumab (MK-3475A) in Participants With Bladder Cancer (MK-2870-055)Merck Sharp & Dohme LLC · recruiting · Bladder Cancer · study director
- Ph3NCT07821944 · A Clinical Study of Enlicitide (MK-0616) in Adults With Hyperlipidemia in India (MK-0616-038)Merck Sharp & Dohme LLC · recruiting · Hyperlipidemia, Hypercholesterolemia · study director
- Ph2NCT07806773 · Study of TUB-040 in Participants With Unresectable or Metastatic Nonsquamous Non-small Cell Lung CancerGilead Sciences · not yet recruiting · NSCLC, Non Small Cell Lung Cancer · study director
- Ph3NCT07805356 · Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic HypoparathyroidismCalcilytix Therapeutics, Inc., a BridgeBio company · recruiting · Hypoparathyroidism, Chronic Hypoparathyroidism · study director
- Ph4NCT07801027 · A Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From India With Different Types of Cancer (MK-3475-G44/KEYNOTE-G44)Merck Sharp & Dohme LLC · not yet recruiting · Neoplasm Malignant, Gastric Neoplasms, Gastroesophageal Junction Adenocarcinoma · study director
- Ph1NCT07798505 · A First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of HMB-003 in Healthy VolunteersHemab ApS · recruiting · Healthy Adult Participants · study director
- Ph2NCT07793942 · A Clinical Trial of MK-2010 Alone and With Other Treatments in Participants With Advanced Solid Tumors (MK-2010-002)Merck Sharp & Dohme LLC · recruiting · Malignant Neoplam, Advanced Solid Tumors · study director
- Ph1NCT07787650 · A Study of S-606001 as Monotherapy in Participants With Late-onset Pompe Disease (LOPD)Shionogi · not yet recruiting · Pompe Disease · study director
- Ph2NCT07785609 · A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010)Merck Sharp & Dohme LLC · recruiting · Advanced Solid Tumors, Malignant Neoplasm · study director
- Ph1NCT07785830 · A Clinical Trial to Evaluate the Effects of MK-4646 on Rosuvastatin in Healthy Participants (MK-4646-007)Merck Sharp & Dohme LLC · active not recruiting · Healthy · study director
- N/ANCT07785154 · A Registry-study of ELZONRIS in Participants With BPDCNStemline Therapeutics, Inc. · recruiting · Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) · study director
- Ph3NCT07785843 · A Clinical Study of V503 in Chinese Females Who Have Previously Received a Bivalent Human Papillomavirus (HPV) Vaccine (V503-108)Merck Sharp & Dohme LLC · recruiting · Papillomavirus Infections · study director
- N/ANCT07785180 · A Non-interventional Study of Participants With BPDCN Treated With ChemotherapyStemline Therapeutics, Inc. · recruiting · Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) · study director
- Ph1NCT07776665 · A Clinical Trial of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-044)Merck Sharp & Dohme LLC · active not recruiting · Healthy · study director
- Ph1NCT07773454 · Study of Zanzalintinib in Children and Adolescents With Relapsed or Refractory Solid TumorsExelixis · not yet recruiting · Cancer, Pediatric Cancer · study director
- Ph1NCT07773129 · A Study to Learn How ASP3082 is Processed in Healthy MenAstellas Pharma Global Development, Inc. · completed · Healthy Volunteer · study director
- Ph2NCT07766018 · A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast CancerStemline Therapeutics, Inc. · recruiting · Breast Cancer · study director
- Ph3NCT07759362 · Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)Endo USA Inc., a Keenova Therapeutics Company · recruiting · Flexible Hammertoe, Semi-flexible Hammertoe · study director
- Ph2NCT07755410 · A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)Alkermes, Inc. · recruiting · Attention Deficit Disorder With Hyperactivity (ADHD) · study director
- Ph1NCT07751250 · Comparative PK Assessment Study of Casdatifan in Moderate Hepatically Impaired Participants Versus Matched Participants With Normal Hepatic FunctionArcus Biosciences, Inc. · recruiting · Healthy Participants, Hepatic Impairment · study director
- Ph2NCT07750990 · An Extension Study of S-606001 in Participants With Late-onset Pompe Disease (LOPD)Shionogi · not yet recruiting · Pompe Disease · study director
- Ph3NCT07750158 · Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual DiseaseExelixis · recruiting · Colorectal Cancer · study director
- Ph1NCT07748351 · A Clinical Trial of Multiple Formulations of MK-4082 in Healthy Overweight and Obese Participants (MK-4082-007)Merck Sharp & Dohme LLC · active not recruiting · Healthy · study director
- Ph3NCT07743580 · A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe DiseaseShionogi · recruiting · SARS-CoV-2 · study director
- Ph1/Ph2NCT07743541 · Study of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After Chemotherapy and Immune TherapyGilead Sciences · not yet recruiting · Uterine Endometrial Cancer · study director
- Ph3NCT07743164 · A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)Merck Sharp & Dohme LLC · recruiting · Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer · study director
- Ph1NCT07743151 · A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)Merck Sharp & Dohme LLC · recruiting · Healthy · study director
- Ph1/Ph2NCT07736937 · Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian CancerGilead Sciences · recruiting · Ovarian Cancer · study director
- Ph1NCT07734610 · A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)Merck Sharp & Dohme LLC · recruiting · Severe Renal Impairment, Healthy · study director
- Ph2NCT07722546 · A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years OldBiogen · recruiting · Graves' Disease · study director
- Ph2/Ph3NCT07722611 · A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025).Merck Sharp & Dohme LLC · recruiting · Polycythemia Vera · study director
- Ph3NCT07719023 · A Phase 3 Study of Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary FibrosisShanghai Ark Biopharmaceutical Co., Ltd. · not yet recruiting · Idiopathic Pulmonary Fibrosis (IPF) · study director
- Ph1NCT07712575 · A Study of V132 in Healthy Older Participants (V132-001)Merck Sharp & Dohme LLC · recruiting · Healthy · study director
- Ph2NCT07709000 · A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)Merck Sharp & Dohme LLC · recruiting · Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Hematologic Malignancies · study director
- Ph3NCT07706764 · A Study to Test the Effects and Safety of Palopegteriparatide in Adolescents With Long-term HypoparathyroidismAscendis Pharma A/S · recruiting · Hypoparathyroidism · study director
- Ph3NCT07705555 · A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)Merck Sharp & Dohme LLC · recruiting · Diabetic Retinopathy, Macular Edema · study director
- Ph3NCT07705607 · A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)Merck Sharp & Dohme LLC · recruiting · Diabetic Retinopathy, Macular Edema · study director
- Ph2NCT07700758 · A Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)Merck Sharp & Dohme LLC · recruiting · Malignant Neoplasm · study director
- Ph1NCT07697625 · A Clinical Trial of MK-4082 in Healthy Participants (MK-4082-005)Merck Sharp & Dohme LLC · completed · Healthy · study director
- Ph2NCT07694440 · A Study of MZE782 in Adults With PKUMaze Therapeutics · recruiting · Phenylketonuria (PKU) · study director
- Ph1NCT07677163 · A Clinical Trial of MK-1403 in Healthy Participants (MK-1403-007)Merck Sharp & Dohme LLC · completed · Healthy · study director
- Ph1NCT07662148 · A Study to Learn More About the Safety of a Single Dose of BIIB144 and How it is Processed in the Body of Healthy Adult Participants Ages 18 to 55 Years Old as Compared to a PlaceboBiogen · recruiting · Healthy Volunteer · study director
- Ph1NCT07662057 · A Study to Investigate the Safety, Tolerability, and PK of AB102 in Healthy ParticipantsArcus Biosciences, Inc. · recruiting · Healthy Volunteers · study director
- Ph1NCT07661108 · A Clinical Study of MK-8527 in Healthy Participants (MK-8527-021)Merck Sharp & Dohme LLC · active not recruiting · Healthy · study director
- Ph2NCT07646860 · A Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032)Merck Sharp & Dohme LLC · recruiting · Pulmonary Arterial Hypertension · study director
- Ph1NCT07641881 · A Bioequivalence Study Between Two Casdatifan Tablet Strengths and Food Effect Study of Casdatifan in Healthy Adult ParticipantsArcus Biosciences, Inc. · completed · Healthy Participants · study director
- Ph2NCT07636811 · A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)Alnylam Pharmaceuticals · recruiting · Down Syndrome-Associated Alzheimer's Disease (DS-AD) · study director
- Ph2/Ph3NCT07634471 · A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)Merck Sharp & Dohme LLC · recruiting · Follicular Lymphoma · study director
- Ph1/Ph2NCT07630974 · A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)Merck Sharp & Dohme LLC · recruiting · Malignant Neoplasm · study director
- Ph1NCT07624071 · A Study to Evaluate ALN-6222 in Participants With ObesityAlnylam Pharmaceuticals · recruiting · Obesity · study director
- Ph1NCT07619443 · A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003)Merck Sharp & Dohme LLC · completed · Healthy · study director
- Ph3NCT07620574 · Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored StudyExelixis · enrolling by invitation · Cancer, Renal Cell Carcinoma (RCC), Pancreatic Neuroendocrine Tumors (pNET) · study director
- Ph2NCT07614984 · A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)Merck Sharp & Dohme LLC · recruiting · Lipoprotein(a) · study director
- Ph1NCT07600749 · Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)Merck Sharp & Dohme LLC · recruiting · Malignant Neoplasm · study director
- Ph4NCT07600723 · A Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) in India (MK-7962-037)Merck Sharp & Dohme LLC · recruiting · Pulmonary Arterial Hypertension · study director
- Ph1NCT07600775 · A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis Infection (MK-8527-019)Merck Sharp & Dohme LLC · not yet recruiting · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis · study director
- Ph1NCT07595263 · A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)Merck Sharp & Dohme LLC · completed · Healthy · study director
- N/ANCT07588880 · A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in ChinaIpsen · recruiting · Progressive Familial Intrahepatic Cholestasis · study director
- N/ANCT07585097 · A Study to Observe the Long-term Safety of Odevixibat in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing TreatmentIpsen · recruiting · Alagille Syndrome · study director
- Ph2NCT07575308 · HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMBAlnylam Pharmaceuticals · recruiting · Von Willebrand Disease (VWD), Heavy Menstrual Bleeding (HMB) · study director
- Ph2/Ph3NCT07570173 · A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)Merck Sharp & Dohme LLC · recruiting · B-cell Acute Lymphoblastic Leukemia · study director
- Ph3NCT07566052 · A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D MutationAstellas Pharma Global Development, Inc. · recruiting · Non-small Cell Lung Cancer (NSCLC) · study director
- N/ANCT07556913 · Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor During PregnancyIpsen · recruiting · Pregnancy Related · study director
- Ph3NCT07554339 · A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)Merck Sharp & Dohme LLC · recruiting · Non-small Cell Lung Cancer · study director
- Ph2NCT07553442 · A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With ZilebesiranAlnylam Pharmaceuticals · recruiting · Hypertension · study director
- Ph1NCT07548606 · A Drug-Drug Interaction Study of Itraconazole and Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-017)Merck Sharp & Dohme LLC · completed · Healthy · study director
- Ph3NCT07540897 · A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)Alkermes, Inc. · recruiting · Narcolepsy Type 1 · study director
- Ph1NCT07535606 · A Study to Evaluate ALN-4915 in Adult Healthy VolunteersAlnylam Pharmaceuticals · active not recruiting · Healthy Volunteers · study director
- Ph1NCT07536061 · A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's DiseaseSarepta Therapeutics, Inc. · recruiting · Huntington's Disease · study director
- Ph1NCT07532304 · A Clinical Trial of MK-4646 With Bictegravir/Emtricitabine/Tenofovir Alafenamide and Dolutegravir in Healthy Adult Participants (MK-4646)Merck Sharp & Dohme LLC · completed · Healthy · study director
- Ph1NCT07530289 · A Clinical Study of Ulonivirine (MK-8507) With Atorvastatin and Metformin in Healthy Adults (MK-8507-018)Merck Sharp & Dohme LLC · completed · Healthy · study director
- Ph1NCT07528508 · A Clinical Trial in Healthy Participants to Study the Effect of a Single Dose of MK-8527 on Levels of Methadone (MK-8527-020)Merck Sharp & Dohme LLC · completed · Healthy · study director
- Ph1/Ph2NCT07519772 · A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)Merck Sharp & Dohme LLC · recruiting · Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse · study director
- Ph3NCT07513376 · A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)Merck Sharp & Dohme LLC · recruiting · Non-small Cell Lung Cancer · study director
- Ph1/Ph2NCT07511556 · First-in-human Study of UX016 in GNEMUltragenyx Pharmaceutical Inc · recruiting · GNE Myopathy · study director
- Ph2/Ph3NCT07496567 · A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)EyeBiotech Ltd. · recruiting · Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization · study director
- N/ANCT07497724 · Odevixibat Outcomes in Patients With PFIC Versus an External Control Cohort (OvEC-PFIC)Ipsen · active not recruiting · PFIC - Progressive Familial Intrahepatic Cholestasis · study director
- Ph3NCT07489495 · A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)Merck Sharp & Dohme LLC · recruiting · Carcinoma, Renal Cell · study director
- Ph2NCT07486960 · Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)Merck Sharp & Dohme LLC · active not recruiting · Psoriatic Arthritis · study director
- Ph3NCT07483632 · A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)Biogen · not yet recruiting · Relapsing Forms of Multiple Sclerosis · study director
- Ph1NCT07481708 · A Clinical Study of the Effect of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-041)Merck Sharp & Dohme LLC · completed · Healthy · study director
- Ph4NCT07477691 · Immune Modulation During Palynziq® Treatment in Adults (IMPALA)BioMarin Pharmaceutical · recruiting · Phenylketonuria · study director
- Ph3NCT07473973 · ENERGY 2: Evaluation of the Efficacy and Safety of INZ-701 in Infants With ENPP1 DeficiencyInozyme Pharma · terminated · Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial Calcification of Infancy 1 · study director
- Ph2NCT07463183 · A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)Merck Sharp & Dohme LLC · recruiting · Colitis Ulcerative, Ulcerative Colitis · study director
- Ph2NCT07465224 · A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes MellitusAlnylam Pharmaceuticals · recruiting · Type 2 Diabetes Mellitus (T2DM) · study director
- Ph1/Ph2NCT07463846 · A Study to Evaluate ALN-2232 in Participants With ObesityAlnylam Pharmaceuticals · recruiting · Obesity · study director
- Ph3NCT07455383 · A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1Alkermes, Inc. · recruiting · Narcolepsy Type 1 · study director
- Ph3NCT07444450 · A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene AbeparvovecBiogen · recruiting · Muscular Atrophy, Spinal · study director
- Ph3NCT07444476 · A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With RisdiplamBiogen · recruiting · Spinal Muscular Atrophy · study director
- Ph3NCT07444489 · A Study to Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) or Microvascular Inflammation (MVI) (TRANSCEND/TRANSPIRE LTE)Biogen · enrolling by invitation · Antibody-mediated Rejection, Microvascular Inflammation · study director
- Ph2/Ph3NCT07441876 · Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With AchondroplasiaBioMarin Pharmaceutical · recruiting · Achondroplasia · study director
- Ph1NCT07441707 · A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults With Brain TumoursIpsen · active not recruiting · Low-grade Glioma · study director
- Ph1NCT07442149 · An Investigational Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of A-005Alumis Inc · completed · Healthy Volunteer · study director
- Ph2/Ph3NCT07440225 · A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)EyeBiotech Ltd. · recruiting · Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization · study director
- Ph1NCT07435194 · A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-2828 Levels and How MK-2828 Affects Midazolam Levels (MK-2828-007)Merck Sharp & Dohme LLC · completed · Healthy · study director
- Ph1NCT07431866 · A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)Merck Sharp & Dohme LLC · completed · Healthy · study director
- Ph3NCT07431827 · MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)Merck Sharp & Dohme LLC · recruiting · Non-small Cell Lung Cancer · study director
- Ph1NCT07430397 · A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CITY-FXI in Healthy Adults, Adults With FV Leiden or Prothrombin G20210A Mutation, and Adults With a History of Provoked Venous ThromboembolismCity Therapeutics · recruiting · Factor V Leiden, Prothrombin G20210A, Venous Thromboembolism (VTE) · study director
- N/ANCT07425574 · A Study to Learn How Stargardt-type Eye Conditions Progress in Children and AdultsAstellas Pharma Global Development, Inc. · recruiting · Stargardt Disease, Stargardt Macular Dystrophy, Stargardt-like Macular Dystrophy · study director
- Ph3NCT07427797 · A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the EyebrowsIpsen · active not recruiting · Moderate to Severe Glabellar Lines · study director
- Ph3NCT07419295 · A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)Merck Sharp & Dohme LLC · recruiting · Bladder Cancer · study director
- Ph3NCT07409272 · A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic CancerAstellas Pharma Global Development, Inc. · recruiting · Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma · study director
- Ph1/Ph2NCT07405151 · A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)Merck Sharp & Dohme LLC · recruiting · Oesophageal Squamous Cell Carcinoma · study director
- Ph3NCT07405164 · Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)Merck Sharp & Dohme LLC · recruiting · Von Hippel-Lindau Disease, Malignant Neoplasms · study director
- Ph1NCT07405177 · A Study of MK-7240 in Healthy Participants (MK-7240-009)Merck Sharp & Dohme LLC · completed · Healthy · study director
- N/ANCT07398469 · A Long-Term Study of Patient-Reported Changes in Postpartum Depression Symptoms in People Starting ZuranoloneBiogen · recruiting · Postpartum Depression · study director
- Ph1NCT07395024 · A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body Processes ASP3082 in Healthy AdultsAstellas Pharma Global Development, Inc. · active not recruiting · Healthy Volunteer · study director
- Ph1NCT07388667 · A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)Merck Sharp & Dohme LLC · completed · Healthy · study director
- Ph3NCT07387549 · A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing CholangitisIpsen · recruiting · Primary Sclerosing Cholangitis · study director
- Ph1NCT07363590 · A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)Merck Sharp & Dohme LLC · recruiting · Systemic Lupus Erythematosus, Rheumatoid Arthritis · study director
- Ph1NCT07364214 · Metabolism, Excretion, and Mass Balance Study of Quemliclustat in Healthy Adult Participants (ARC-24)Arcus Biosciences, Inc. · completed · Healthy Participants · study director
- N/ANCT07358078 · DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World SettingAlnylam Pharmaceuticals · recruiting · Transthyretin Amyloidosis With Cardiomyopathy · study director
- Ph1NCT07348237 · A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)Merck Sharp & Dohme LLC · completed · Chronic Kidney Failure, End-Stage Renal Disease, Renal Impairment · study director
- N/ANCT07345494 · A Global Pregnancy Registry to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to YORVIPATH® (Palopegteriparatide) During Pregnancy and BreastfeedingAscendis Pharma A/S · recruiting · Hypoparathyroidism · study director
- Ph1NCT07334860 · A Clinical Trial to Compare Forms of MK-1167 in Healthy People (MK-1167-011)Merck Sharp & Dohme LLC · completed · Healthy · study director
- Ph1NCT07334886 · A Study of [14C]Ulonivirine ([14C]MK-8507) in Healthy Adults (MK-8507-006)Merck Sharp & Dohme LLC · completed · Healthy · study director
- Ph1/Ph2NCT07318714 · A Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a StrokeAstellas Pharma Inc · recruiting · Chronic Ischemic Stroke · study director
- Ph3NCT07318558 · A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)Merck Sharp & Dohme LLC · recruiting · Ovarian Neoplasms, Ovarian Cancer · study director
- N/ANCT07314164 · Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior TreatmentIpsen · recruiting · Neuroendocrine Tumors · study director
- Ph1NCT07305831 · A Clinical Trial to Evaluate the Effect of Ulonivirine (MK-8507) on Heart Rhythm in Healthy Adults (MK-8507-012)Merck Sharp & Dohme LLC · completed · Healthy · study director
- Ph1/Ph2NCT07302347 · A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)Merck Sharp & Dohme LLC · recruiting · Malignant Neoplasm, Carcinoma, Merkel Cell, Lymphoma · study director
- Ph1NCT07300280 · A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)Merck Sharp & Dohme LLC · completed · Healthy · study director
- Ph1NCT07300085 · A Trial to Evaluate the Effect of CD388/MK1406 on the Immunogenicity of Fluzone® HD Vaccine (CD388.SQ.1.08/MK-1406-007)Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · recruiting · Healthy Participants · study director
- Ph1NCT07300267 · A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)Merck Sharp & Dohme LLC · recruiting · Pneumococcal Infection · study director
- Ph1NCT07297199 · A Study to Learn How the Body Processes BIIB141 (Omaveloxolone) When Taken as a Capsule or as a Tablet Dissolved in Liquid, and to Learn About Its Safety in Healthy Adults Ages 18 to 55Biogen · completed · Healthy Volunteer · study director
- Ph1NCT07295717 · A Study to Evaluate ALN-4285 in Adult Healthy VolunteersAlnylam Pharmaceuticals · recruiting · Healthy Volunteers · study director
- Ph3NCT07287163 · Clinical Trial of Vormatrigine in Adult Patients With EpilepsyPraxis Precision Medicines · enrolling by invitation · Epilepsy, Tonic-Clonic, Focal Seizure, Primary Generalized Seizure · study director
- Ph3NCT07284875 · Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have DiabetesKailera · active not recruiting · Obesity, Overweight · study director
- Ph3NCT07284979 · Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have DiabetesKailera · active not recruiting · Obesity · study director
- Ph1/Ph2NCT07286149 · A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)Merck Sharp & Dohme LLC · recruiting · Lung Neoplasm Malignant · study director
- Ph3NCT07284901 · Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and DiabetesKailera · active not recruiting · Obesity With Diabetes, Overweight With Diabetes · study director
- N/ANCT07282548 · Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two TherapiesIpsen · withdrawn · Follicular Lymphoma · study director
- Ph2/Ph3NCT07266831 · A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)Merck Sharp & Dohme LLC · recruiting · Human Immunodeficiency Virus Type 1 (HIV-1) Infection · study director
- Ph1NCT07266818 · A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)Merck Sharp & Dohme LLC · completed · Healthy · study director
- N/ANCT07264634 · A Study to Assess the Amount of Palopegteriparatide in Breast Milk of Lactating Females Requiring YORVIPATH® (Palopegteriparatide)Ascendis Pharma A/S · recruiting · Hypoparathyroidism · study director
- N/ANCT07259980 · A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)Biogen · recruiting · Amyotrophic Lateral Sclerosis · study director
- Ph1NCT07254728 · A Study to Evaluate Vaxart's Oral Bivalent GI.1/GII.4 Norovirus Vaccine in Healthy Lactating Females and Their Nursing InfantsVaxart · completed · Norovirus Infections · study director
- Ph2NCT07252739 · KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)Merck Sharp & Dohme LLC · recruiting · Malignant Neoplasm · study director
- Ph1NCT07247110 · A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)Merck Sharp & Dohme LLC · recruiting · Malignant Neoplasm · study director
- Ph1NCT07242469 · A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)Merck Sharp & Dohme LLC · completed · Diabetes Mellitus, Type 2 · study director
- Ph1NCT07232589 · A Study of the Effect of Diltiazem on the Plasma Levels of Nemtabrutinib (MK-1026-022)Merck Sharp & Dohme LLC · completed · Healthy · study director
- Ph1/Ph2NCT07232602 · KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)Merck Sharp & Dohme LLC · recruiting · Bladder Cancer · study director
- Ph3NCT07227402 · A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)Merck Sharp & Dohme LLC · recruiting · Renal Cell Carcinoma · study director
- Ph1/Ph2NCT07227597 · A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)Merck Sharp & Dohme LLC · recruiting · Small Cell Lung Cancer Extensive Stage · study director
- Ph1NCT07226427 · A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian CancerStemline Therapeutics, Inc. · recruiting · Platinum-resistant Ovarian Cancer · study director
- Ph2NCT07225959 · A Study of Annual Doses of MK-1406/CD388 in Healthy Adults (MK-1406-006/CD388.SQ.2.07)Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · active not recruiting · Healthy Participants · study director
- Ph1NCT07225517 · A Study to Learn More About the Safety of BIIB145 and How it is Processed in the Body of Healthy Adult ParticipantsBiogen · recruiting · Healthy Volunteer · study director
- Ph2NCT07224477 · A Clinical Study of V540A in Healthy Female Participants (V540A-005)Merck Sharp & Dohme LLC · withdrawn · Healthy · study director
- Ph4NCT07223723 · A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese Participants With SOD-1 Amyotrophic Lateral Sclerosis (ALS)Biogen · active not recruiting · Amyotrophic Lateral Sclerosis · study chair
- Ph3NCT07223203 · TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With PolyneuropathyAlnylam Pharmaceuticals · recruiting · Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy, hATTR-PN · study director
- Ph1/Ph2NCT07222488 · A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)Merck Sharp & Dohme LLC · recruiting · Bladder Cancer, Urinary Bladder Neoplasms · study director
- Ph1NCT07222098 · A Clinical Study of Calderasib (MK-1084) With Rosuvastatin and Metformin in Healthy People (MK-1084-016)Merck Sharp & Dohme LLC · completed · Healthy · study director
- Ph2NCT07221474 · A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)Merck Sharp & Dohme LLC · recruiting · Squamous Non-small Cell Lung Cancer · study director
- Ph3NCT07221669 · A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)Biogen · recruiting · Muscular Atrophy, Spinal · study director
- Ph3NCT07221851 · Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient DisordersAscendis Pharma A/S · recruiting · Turner Syndrome, Short Stature Homeobox Gene Mutation, Idiopathic Short Stature · study director
- Ph1NCT07219550 · A Study of Calderasib (MK-1084) in Participants With Hepatic Impairment and Healthy Volunteers (MK-1084-017)Merck Sharp & Dohme LLC · completed · Healthy, Hepatic Impairment · study director
- Ph2NCT07219043 · A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular InflammationBiogen · recruiting · Microvascular Inflammation · study director
- Ph3NCT07218029 · A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)Merck Sharp & Dohme LLC · active not recruiting · Pulmonary Arterial Hypertension · study director
- Ph3NCT07216703 · A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)Merck Sharp & Dohme LLC · recruiting · Cervical Cancer · study director
- Ph3NCT07216482 · A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)Merck Sharp & Dohme LLC · active not recruiting · Hyperlipidemia · study director
- Ph1/Ph2NCT07213830 · A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor TherapiesIpsen · recruiting · Advanced Solid Tumor, Metastatic Solid Tumor · study director
- Ph1NCT07214727 · A Study to Evaluate ALN-5288 in Patients With Alzheimer's DiseaseAlnylam Pharmaceuticals · recruiting · Alzheimer's Disease · study director
- Ph1/Ph2NCT07213817 · A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid TumoursIpsen · recruiting · Locally Advanced Solid Tumor, Metastatic Solid Tumor · study director
- Ph2NCT07209332 · Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular DystrophyWave Life Sciences USA, Inc. · enrolling by invitation · Duchenne Muscular Dystrophy · study director
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:55 UTC. The ranking covers the 200 most relevant of 1 PubMed records, and a shared surname and initials can bring in a namesake. All 1 on PubMed